Synthetic Vaccine Biotech

BiotechnologySeries BBeijing, China

Latest round

Series B

Last raised

Jul 2025

Total raised

Undisclosed

Investors

1

About Synthetic Vaccine Biotech

, focuses on the development of vaccines, adjuvants, and antibody-based therapies. The company operates as a biotechnology firm serving the biopharmaceutical sector. The company specializes in vaccine development, adjuvant technologies and antibody-drug conjugates (ADCs), along side wit biomedical research to support clinical applications and commercialization of therapeutic and preventive products in the life sciences sector. The company generates revenue through research collaboration, licensing agreements, and the development and commercialization of vaccines and therapeutic antibody products.

Who invested in Synthetic Vaccine Biotech

1 investor across 1 round

See all investors in Synthetic Vaccine Biotech

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Jul 21, 2025

    Amount

    Undisclosed

    Investors

    Locked

Questions about Synthetic Vaccine Biotech

Who invested in Synthetic Vaccine Biotech?

Synthetic Vaccine Biotech has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Synthetic Vaccine Biotech raised?

Synthetic Vaccine Biotech has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Synthetic Vaccine Biotech last raise money?

Synthetic Vaccine Biotech's most recent round on record is a Series B, in Jul 2025.

What does Synthetic Vaccine Biotech do?

, focuses on the development of vaccines, adjuvants, and antibody-based therapies.

Where is Synthetic Vaccine Biotech headquartered?

Synthetic Vaccine Biotech is headquartered in Beijing, China.

Which VCs invest in companies like Synthetic Vaccine Biotech?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Synthetic Vaccine Biotech's stage. Their profiles are linked below.

Raising like Synthetic Vaccine Biotech? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.